A 6-week, Study of MG01CI Low Dose and High Dose Compared With Placebo in Adults and Adolescents With Fragile X Syndrome

Clinical trial NCT02126995 · COMPLETED

Trial details

NCT number: NCT02126995
Sponsor: Alcobra Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fragile X Syndrome

Start date: 2014-06-01
Primary completion: 2015-06-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.